CoChat

Interferences With CGM Systems: Practical Relevance?

Open access
Heinemann, Lutz · 2022 · Journal of Diabetes Science and Technology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Most systems for continuous glucose monitoring (CGM) are based on a specific electrochemical methodology for measuring glucose in interstitial subcutaneous fluid (ISF). The enzymes needed for the enzymatic reaction are located at the tip of the filaments that are inserted into the subcutaneous tissue using needles. However, depending on the particular enzyme chemistry and the voltage applied to measure the electron flow in relation to the glucose concentration in the ISF around the sensor tip, other substances can also influence the measurements taken by CGM systems, that is, shift the “glucose” data in one direction or the other. These interfering substances can be endogenous substances, as well as drugs or food components circulating in the human body. Despite the potential impact of interfering substances on CGM accuracy, there are few publications focusing on the interference of drugs and other substances on CGM system measurements.1-3 In addition, the CGM systems tested in these studies are mostly outdated. Manufacturers are required to perform interference studies during the clinical development process for each new CGM system and product generation to gain regulatory approval. However, the data generated by most of these studies are not published. Although interferences are well known and relevant when it comes to systems for self-measurement of blood glucose (SMBG), once again, publications are sparse.4 In this editorial, the publicly available information about interfering substances and how they influence glucose measurements from various CGM systems, manufactured by different companies, are summarized, with a focus on the clinical situation of people with diabetes (PwD). The subsequent summary is not comprehensive and will not cover all available CGM systems.

Overview

Integrity signals

Registry

Crossref · 10.1177/19322968211065065

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. Schiavon M, 2018, Annu Int Conf IEEE Eng Med Biol Soc, 2018, 159

Cited by

See all 73

Metadata

Authors
Heinemann, L.
Affiliations
Science-Consulting in Diabetes GmbH, Kaarst, Germany
Corresponding author
Heinemann, Lutz
Venue
Journal of Diabetes Science and Technology
Published
2021-12-15
Volume
16
Issue
2
Pages
271-274
ISSN
1932-2968 (ISSN-L)
OpenAlex
W4200166937
Cited by
65
References
20
Citations by year
2026: 16 · 2025: 18 · 2024: 19 · 2023: 9 · 2022: 3
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Engineering › Biomedical Engineering › Wireless Body Area Networks
  • Health Sciences › Medicine › Surgery › Healthcare Technology and Patient Monitoring
Keywords
continuous glucose monitoring, sensor interference, diabetes management
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Humans, Insulin Infusion Systems, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interferences With CGM Systems: Practical Relevance? https://app.cochat.ai/papers/10.1177/19322968211065065
The paper
Heinemann, L. (2022). Interferences With CGM Systems: Practical Relevance? Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968211065065

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.